Axys Pharmaceuticals, Inc. is a drug discovery and development company with a proprietary focus in oncology. Axys is building shareholder value through (1) a broad and diversified pipeline of research and development programs partnered with world-class pharmaceutical companies; (2) expansion of a non-partnered research and development franchise in oncology; and (3) the spin out of affiliated businesses that leverage the company's technologies in order to provide capital for Axys' drug discovery and development programs. Axys' technology-leveraging businesses are: Axys Pharmaseutics, Inc., a wholly owned combinatorial chemistry oriented company; xGS Tech, a majority owned pharmacogenomics company; a majority owned agricultural biotechnology company.